[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368294-105":59,"doc-detail-368294-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-transcriptomic-architecture-of-common-cancers-reflects-synthetic-lethal-interactions-received-accepted-dates","The transcriptomic architecture of common cancers reflects synthetic lethal interactions - Received Accepted dates","","Integrating transcriptomic profiling from 9,316 human tumors with genome-wide CRISPR–Cas9 synthetic lethal screens, this study shows that loss of tumor suppressor genes is frequently buffered by hyperexpression of synthetic lethal partners. The buffering pattern extends across multiple tumor suppressor genes and cancer subtypes, including BRCA1/2 phenocopy contexts where expression of synthetic lethal genes correlates with clinical outcome. Buffering-associated synthetic lethal genes also produce more robust lethal effects, informing models of tumor fitness tolerance and guiding target selection for therapy.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-transcriptomic-architecture-of-common-cancers-reflects-synthetic-lethal-interactions-received-accepted-dates/368294/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-transcriptomic-architecture-of-common-cancers-reflects-synthetic-lethal-interactions-received-accepted-dates/368294.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does the study address about synthetic lethality in cancer?","Question",{"text":113,"@type":114},"Although synthetic lethal interactions were widely identified in preclinical models, clinical evidence for their operation is limited. The study evaluates whether transcriptomic buffering relationships occur in human cancers.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does SYLVER combine data to find buffering relationships?",{"text":118,"@type":114},"SYLVER integrates CRISPR–Cas9 perturbation screen results with genome-wide molecular profiles across TCGA tumors. It links tumor suppressor gene defects to candidate synthetic lethal genes and identifies transcriptomic hyperexpression patterns.",{"name":120,"@type":111,"acceptedAnswer":121},"What does the study conclude about tumor suppressor gene loss and therapy targeting?",{"text":122,"@type":114},"Transcriptomic buffering of tumor suppressor gene loss by synthetic lethal partner hyperexpression is common and extends across many tumor types. These buffering-associated synthetic lethal genes also show more robust lethal effects, supporting implications for target selection and biomarker development.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},368294,1790196341,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":19,"preview_urls":145},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","nature genetics  \nLetter [https://doi.org/10.1038/s41588-025-02108-2](https://doi.org/10.1038/s41588-025-02108-2)  \nThe transcriptomic architecture of common cancers reflects synthetic lethal interactions  \nReceived: 18 April 2024  \nAccepted: 28 January 2025  \n\n| Published online: 3 March 2025 |\n| --- |\n|  Check for updates |\n\nSyed Haider  1 , Rachel Brough1,2,3, Santiago Madera  1,3, Jacopo Iacovacci1, Aditi Gulati1, Andrew Wicks  1,2, John Alexander1, Stephen J. Pettitt  1,2 , Andrew N. J. Tutt  1  & Christopher J. Lord  1,2   \nTo maintain cell fitness, deleterious genetic alterations are buffered by compensatory changes in additional genes. In cancer, buffering processes could be targeted by synthetic lethality. However, despite the large-scale identification of synthetic lethal effects in preclinical models, evidence that these operate clinically is limited. This impedes the application of synthetic lethal approaches. By integrating molecular profiling data from >9,000 cancers with synthetic lethal screens, we show that transcriptomic buffering of tumor suppressor gene (TSG) loss by hyperexpression of synthetic lethal partners is a common phenomenon, extending to multiple TSGsand histotypes. Transcriptomic buffering is also notable in cancers that phenocopy TSGloss, such as BRCAness cancers, where expression of BRCA1/2 synthetic lethal genes correlates with clinical outcome. Synthetic lethal genes that exhibit transcriptomic buffering also represent more robust synthetic lethal effects. These observations have implications for understanding how tumor cells tolerate TSGloss, in part explain transcriptomic architectures in cancer and provide insight into target selection.  \nLoss of tumor suppressor genes (TSGs) is critical to oncogenic transformation1. Although providing fitness advantages to cells, TSG loss can also impart deleterious phenotypes, which, if not buffered, impair cell fitness. Buffering processes that compensate for TSG loss are sometimes unveiled as synthetic lethal effects with TSGs. For example, although loss-of-function mutations in BRCA1 or BRCA2 impair homologous recombination (HR) and foster genomic instability and mutagenesis, they also, in certain circumstances, invoke a proliferative defect2. The negative impact of BRCA1 orBRCA2mutation on tumor cells is in part ameliorated by buffering from other DNA-repair and genome stability mechanisms such as Polθ-mediated end-joining3–6 and CIP2A-mediated processes that maintain the integrity of mitotic chromosomes7. The importance of these two buffering processes was recently confirmed by the identification of synthetic lethal interactions between BRCA1 orBRCA2 (BRCA1/2) and either Polθ3–6 or CIP2A7. On a  \nwider scale, the mapping of synthetic lethal relationships, often using genetic perturbation screens, has identified buffering processes that compensate for gene loss in tumor cell lines and model organisms such as yeast8–13. However, to date, a systematic assessment of whether synthetic lethal effects identified by experimental perturbation screens operate inhuman cancers has been missing. We reasoned that, if evidence of buffering relationships between TSGs and synthetic lethal genes could be established in human tumors, this could potentially explain the molecular make-up of human cancers and also possibly identify subsets ofthe disease where synthetic lethal buffering relationships could be exploited therapeutically.  \nWe developed an analytical approach, SYLVER (SYnthetic Lethal Vulnerabilities Exhibiting Reciprocation), that integrates CRISPR–Cas9 perturbation screen data with genome-wide molecular profiles from 9,316 tumours representing 32 tumor subtypes to identify buffering  \n1Breast Cancer Now Toby Robins Breast Cancer Research Centre, London, UK. 2CRUK Gene Function Laboratory, The Institute of Cancer Research,  \nLondon, UK. 3These authors contributed equally: Rachel Brough, Santiago Madera. [e-mail:](e-mail: Syed.Haider@icr.ac.uk)[ Syed.Haider@","cbCaicInY3SLpy6A","https://ap.wps.com/l/cbCaicInY3SLpy6A","pdf",6760028,"English","# Background\n## Tumor suppressor loss and synthetic lethal buffering\n# Methodology\n## SYLVER framework integrating screens and molecular profiles\n## Classification of tumor cell line defects\n# Results\n## Hyperexpression of synthetic lethal partners as buffering\n## Clinical relevance in BRCA1/2 phenocopy cancers\n## Robustness of buffering-associated synthetic lethal effects\n# Implications","[{\"question\":\"What problem does the study address about synthetic lethality in cancer?\",\"answer\":\"Although synthetic lethal interactions were widely identified in preclinical models, clinical evidence for their operation is limited. The study evaluates whether transcriptomic buffering relationships occur in human cancers.\"},{\"question\":\"How does SYLVER combine data to find buffering relationships?\",\"answer\":\"SYLVER integrates CRISPR–Cas9 perturbation screen results with genome-wide molecular profiles across TCGA tumors. It links tumor suppressor gene defects to candidate synthetic lethal genes and identifies transcriptomic hyperexpression patterns.\"},{\"question\":\"What does the study conclude about tumor suppressor gene loss and therapy targeting?\",\"answer\":\"Transcriptomic buffering of tumor suppressor gene loss by synthetic lethal partner hyperexpression is common and extends across many tumor types. These buffering-associated synthetic lethal genes also show more robust lethal effects, supporting implications for target selection and biomarker development.\"}]","The transcriptomic architecture of common cancers reflects synthetic lethal interactions - Received Accepted dates | PDF",1790176087,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/377281f3553eaa33ccd76b042d8b2d63.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e511b2ad6a75f884e5c4f05966089a9.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6ff2cf6ac16df9ad10b53b21bbbf50d.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/471bc189d49cfbb59f5e643cab39a279.webp",980,1301]